Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen
Authors:
Open Access
- 16 January 2006
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 37 (4) , 411-418
Abstract
Hematopoietic cell transplantation (HCT) following nonmyeloablative conditioning (NMSCT) may be associated with a reduced risk of infection compared to standard allogeneic HCT. We retrospectively analyzed incidence and risk factors of infection in 62 patients undergoing NMSCT with low-dose TBI +/− fludarabine and postgrafting CsA and MMF. The proportion of patients with any infection was 77%, but the majority of infectious events occurred beyond day 30. Donor other than sibling, older age, early disease and male gender were significant risk factors. The incidence of bacteremia was 55% at 1 year and the number of bacteremic episodes was 0.9 per patient (0.08 before day 30). The risk of bacteremia increased with older age and the use of a donor other than an HLA-identical sibling, but not with neutropenia. The incidence of infections other than bacteremia correlated with the use of corticosteroids. The risk of CMV infection increased with high-risk CMV serology, and risk of CMV disease with high-risk CMV serology, older age, first transplantation and a diagnosis of lymphoma. In conclusion, after NMSCT, infections are not frequent in the first 30 days post transplant but careful long-term monitoring is necessary thereafter.Keywords
This publication has 35 references indexed in Scilit:
- Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantationTransplantation and Cellular Therapy, 2004
- T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantationTransplantation, 2003
- Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioningBlood, 2003
- Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseasesBlood, 2003
- Allogeneic hematopoietic stem cell transplantation—Yesterday, today, and tomorrowExperimental Hematology, 2003
- Nonmyeloablative Allogeneic Hematopoietic Stem Cell TransplantationJournal of Hematotherapy & Stem Cell Research, 2002
- Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 2001
- Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 2001
- Mixed chimerism: Preclinical studies and clinical applicationsTransplantation and Cellular Therapy, 1999
- 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverClinical Infectious Diseases, 1997